MedPage Today on MSN
Ocrelizumab Shows Hand Function Benefits in Advanced Progressive MS
In a large PPMS population that included older patients and people with more advanced disease, ocrelizumab led to a 30% risk ...
In the field of high-end equipment manufacturing, Tengzhou Shandong Dahan Intelligent Technology Co., Ltd. has launched the ...
Tech Xplore on MSN
Tiny amphibious soft robot hauls cargo across land and water with ease
Could the future of rescue missions and exploration lie in the hands—or rather, the flexible movements—of a swarm of ...
For dental professionals, managing root caries means mastering risk assessment, patient education, and new tools like silver ...
A new phase III clinical trial finds that intensity-modulated radiation therapy (IMRT) and proton beam therapy resulted in ...
To strengthen its policy expertise, Quatrefoil has brought on former CFTC Chair J. Christopher Giancarlo as an advisor.
A durable MOF-nanofiber composite overcomes the fragility of reactive materials, enabling real-world systems that capture and ...
Already approved for progressive multiple sclerosis, ocrelizumab in a second phase 3 study demonstrates meaningful clinical ...
News-Medical.Net on MSN
Proton therapy and IMRT show similar outcomes in head and neck cancer trial
A new phase III clinical trial finds that intensity-modulated radiation therapy (IMRT) and proton beam therapy resulted in ...
Wall Street drifted a bit higher after a day of mixed trading. The S&P 500 added 0.3% Monday. The Dow Jones Industrial Average edged up 0.1%, and the Nasdaq composite rose 0.5%. All three are ...
Could a simple blood test reveal how well someone is aging? A team of researchers led by Wolfram Weckwerth from the ...
Jason Tan Jing Shen has been named managing director for Michelin in Vietnam, Cambodia, Laos, and Myanmar. Jason Tan leads Michelin’s strategic direction and overseas operations across the four ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results